The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.
October 3rd 2024
A study reveals that individuals with schizophrenia spectrum disorders experience high rates of comorbid mental health conditions and receive minimally adequate treatment.
September 26th 2024
September 20th 2024
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
CDC: 1 in 68 US Children Identified with Autism Spectrum Disorder
The latest US Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report estimated one in 68 children have been identified with autism spectrum disorder - an increase of 23% from the 2008 study.
Have We Reached the Tipping Point When it Comes to Opioid Therapy?
March 18th 2014While the peak of the opioid epidemic may now have been reached (according to some), we are not out of the woods. Every decision to start or continue opioid therapy must be careful, deliberate, and weigh benefit against risk, while keeping in mind that risk is not constant/static, but dynamic and evolves through time.
Nicotine Withdrawal Weakens Brain Interconnectivity while Quitting Smoking
As evidenced in brain scans after abstaining from smoking for 24 hours, smokers were likely to show weakened interconnectivity between brain networks, according to a study published in JAMA Psychiatry.
With Behavioral Support in Place, Opioid Dose Reduction Does Not Exacerbate Pain or Function
Reducing high-dose opioid therapy does not worsen pain severity, functional ability, or aberrant drug-related behaviors in chronic pain patients when concurrent biopsychosocial services are offered.
Predicting Positive and Negative Symptom Exaggeration in Chronic Pain Patients
Sometimes, chronic pain patients intentionally magnify or downplay their physical and mental symptoms during office visits. Despite that fact, little attention in the clinical setting is paid to underlying motives for positively or negatively biased self-reports.
Mindfulness-based Pain Care Provides Opioid Taper Support
Even if a chronic pain patient had been taking opioid medications exactly as prescribed, it would still be possible for the patient to experience negative cognitive and emotional responses to dose tapering that could amplify sensory pain and lead to opioid addiction.
Can a Smoking Cessation Drug Cause Neuropsychiatric Adverse Events?
March 7th 2014When encouraging and supporting patients to quit smoking, varenicline is unlikely to increase the risk of neuropsychiatric adverse events such as suicide, depression, and aggression, even in patients with pre-existing psychiatric illness.
Grouping Fibromyalgia Patients by Symptom Incidence, Severity May Improve Treatment Outcomes
Although fibromyalgia lacks an effective standardized treatment, one part of the problem is the condition's diverse constellation of symptoms that include chronic widespread pain, fatigue, and even depression.
Healthcare Coalition Decries FDA Approval of Extended-Release Zohydro
A 40-member coalition partly comprised of physician experts on opioid addiction treatment and overdose prevention is asking the US Food and Drug Administration to rescind its approval of extended-release Zohydro (hydrocodone bitratrate), given the drug's perceived dangers to the public.
Metabolic Changes Accelerate Cognitive Decline in Type 2 Diabetics
March 3rd 2014Examining evidence from epidemiologic, clinical, and animal studies, a team of researchers discussed the connection between neural dysfunction and metabolic disorders related to type 2 diabetes in the February 2014 issue of Current Diabetes Reports.